Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target encompasses the diverse set of microbial cell wall-associated proteins that are vulnerable to oxidation reactions. Bacterial survival depends heavily on the integrity of their cell walls composed mainly of peptidoglycan layers synthesized by enzymes like MurA-MurF ligases. Oxidative stress—whether from ionizing radiation or antimicrobial blue light—primarily damages these cellular components by inducing protein carbonylation and disrupting membrane integrity rather than directly damaging DNA. The degree of susceptibility varies among bacteria depending on intracellular metal ion concentrations influencing redox chemistry. Therapeutic strategies exploit this vulnerability either by direct inhibition of biosynthetic enzymes critical for maintaining the structural integrity or by promoting reactive oxygen species formation that selectively oxidizes essential microbial proteins leading to bactericidal effects. Additionally, bacteria have evolved enzymatic defenses such as superoxide dismutases which modulate their response to oxidative stress. This broad molecular class represents an important focus area for developing novel antimicrobials aimed at overcoming resistance mechanisms through targeted disruption via oxidation-based modalities.
Drugs or treatments targeting these molecules often induce protein oxidation leading to loss of function and bacterial death. They can also inhibit key enzymes involved in cell wall biosynthesis, or generate reactive oxygen species causing membrane disruption and protein carbonylation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell wall proteins susceptible to oxidative modification (None).